Longboard Pharmaceuticals Inc.

11/12/2024 | Press release | Distributed by Public on 11/12/2024 08:43

Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)